Composite Health Assessment Risk Model (CHARM) for Older Adults (BMT CTN 1704)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew Artz, MD, MS
City of Hope Medical Center
Principal Investigator - Mohamed Sorror, MD, MSc
Fred Hutchinson Cancer Center
Principal Investigator - Wael Saber, MD, MS
Medical College of Wisconsin/CIBMTR
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
50 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Arizona and Phoenix Children'S Hospital
Phoenix, Arizona, United States
- City of Hope National Medical Center
Duarte, California, United States
- University of California San Francisco
San Francisco, California, United States
- Stanford University
Stanford, California, United States
- University of Florida
Gainesville, Florida, United States
- Adventhealth Orlando
Orlando, Florida, United States
- Memorial Cancer Institute
Pembroke Pines, Florida, United States
- H. Lee Moffitt Cancer Center
Tampa, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Northside Hospital
Atlanta, Georgia, United States
- University of Chicago Medicine
Chicago, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Indiana Blood and Marrow Transplantation
Beech Grove, Indiana, United States
- Indiana University
Indianapolis, Indiana, United States
- University of Kansas, Blood and Marrow Transplant Program
Kansas City, Kansas, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- Umass Memorial Medical Center
Worcester, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Henry Ford Hospital Bone Marrow Transplant Program
Detroit, Michigan, United States
- Karmanos Cancer Center
Detroit, Michigan, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Mayo Clinic Rochester
Rochester, Minnesota, United States
- Washington University
St Louis, Missouri, United States
- Nebraska Medicine
Omaha, Nebraska, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Mount Sinai Medical Center
New York, New York, United States
- New York Presbyterian Hospital/columbia University Medical Center
New York, New York, United States
- Unc Chapel Hill
Chapel Hill, North Carolina, United States
- Levine Cancer Institute
Charlotte, North Carolina, United States
- Duke University
Durham, North Carolina, United States
- Wake Forest Baptist Health
Winston-Salem, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Siedman Cancer Center
Cleveland, Ohio, United States
- the Ohio State Universtiy
Columbus, Ohio, United States
- Hca Health Services of Oklahoma, Inc., University of Ok
Oklahoma City, Oklahoma, United States
- Oregon Health and Science University
Portland, Oregon, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Jul 2019
- Primary completion
- 29 May 2023
- Completion
- 30 May 2023
- Last update posted
- 6 Feb 2024
- Registered enrollment
- 1,229
- Registry id
- NCT03992352
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.